发明名称 NOVEL FGFR3 FUSION PRODUCT
摘要 [Problem] The present invention aims to elucidate a polynucleotide as a novel responsible gene for cancer and aims to thus provide a method for detecting the polynucleotide and a polypeptide encoded by the polynucleotide and a detection kit, a probe set, and a primer set for the detection. The present invention also aims to provide a pharmaceutical composition for treating cancer. [Means for Solution] The method detects a fusion gene composed of a portion of an FGFR3 gene and a portion of a TACC3 gene or a fusion protein encoded by the fusion gene. The primer set, the probe set, or the detection kit comprises a sense primer and a probe set designed from the portion encoding FGFR3 and an antisense primer and a probe set designed from the portion encoding TACC3. Since an inhibitor of the polypeptide exhibits antitumor effect, a pharmaceutical composition for treating cancer which is positive for either the fusion gene or the polypeptide is provided.
申请公布号 KR20140140070(A) 申请公布日期 2014.12.08
申请号 KR20147028041 申请日期 2013.03.07
申请人 ASTELLAS PHARMA INC. 发明人 SUZUKI ATSUSHI;ASAUMI MAKOTO;TSUNOYAMA KAZUHISA;NISHIMURA KOUICHI;MORINAKA AKIFUMI;YAMAUCHI TOMOHIRO;YOSHINO MASAYASU;YOSHIZAKI HIROAKI
分类号 C12Q1/68;A61K45/00;A61P35/00;C12N15/09;G01N33/53 主分类号 C12Q1/68
代理机构 代理人
主权项
地址